Bumetanide (Compound)

Synonyms:bumetanide, 28395-03-1, 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid, Bumex, Burinex, Fordiuran, Lunetoron, Fontego, Segurex, Ro 10-6338, Bumetanida, Bumetanidum, Bumetanidum [INN-Latin], 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid, Bumetanida [INN-Spanish], PF 1593, Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, UNII-0Y2S3XUQ5H, C17H20N2O5S, 0Y2S3XUQ5H, MLS000028457, CHEBI:3213, Aquazone, Butinat, Cambiex, Diurama, Yurinex, BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL-, Burine, 3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid, 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid, Lixil-Leo, MFCD00078949, NCGC00015149-02, SMR000058418, Lixil, CAS-28395-03-1, Ro 10-6338;PF 1593, DSSTox_CID_2699, 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid, DSSTox_RID_76695, DSSTox_GSID_22699, Bufenox, Bumex (TN), SR-01000003062, EINECS 249-004-6, BRN 2185351, Bumetanide (Ro 10-6338), Prestwick_679, Bumetanide [USAN:USP:INN:BAN:JAN], Ro-10-6338, Spectrum_001317, Bumetanide, >=98%, Opera_ID_1734, Prestwick0_000276, Prestwick1_000276, Prestwick2_000276, Prestwick3_000276, Spectrum2_001050, Spectrum3_001481, Spectrum4_000030, Spectrum5_001212, Lopac-B-3023, B 3023, cid_2471, CHEMBL1072, Lopac0_000162, SCHEMBL27525, BSPBio_000152, BSPBio_001508, BSPBio_003061, KBioGR_000228, KBioGR_000439, KBioSS_000228, KBioSS_001797, 3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid, MLS001148265, DivK1c_000034, SPECTRUM1502004, SPBio_000980, SPBio_002371, BPBio1_000168, Bumetanide (JP17/USP/INN), GTPL4837, DTXSID5022699, BDBM25903, HMS500B16, KBio1_000034, KBio2_000228, KBio2_001797, KBio2_002796, KBio2_004365, KBio2_005364, KBio2_006933, KBio3_000455, KBio3_000456, KBio3_002561, NINDS_000034, 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid, Bio1_000421

Pubchem:PUBCHEM:2471

Id:2471

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Bumetanide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Bumetanide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Bumetanide.

Results found

Linked to

	Label	Description
	BRD-K38197229-001-17-4 Substance (Entity type)	A Substance
	bumetanide (81244eab-aaf4-42b3-b3e3-bc8984958dc7) Collection (Entity type)	Metadatata for bumetanide
	DCSTRUCT ID 00427 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00427; PubChem_CID:2471, FILE=drugcentral_drug_00427.json)
	bumetanide negatively regulates NUPR1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bumetanide negatively regulates RPS4Y1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bumetanide positively regulates PRPF4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bumetanide indication Edema Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	bumetanide positively regulates AQP3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bumetanide negatively regulates CYP1B1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bumetanide positively regulates WFDC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS